Seven Eight Capital, LP Becton Dickinson & CO Transaction History

Seven Eight Capital, LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$225.07 - $246.17 $1.91 Million - $2.08 Million	8,465 New	8,465 $1.98 Million
Q4 2023 Feb 13, 2024	BUY	$232.24 - $267.23 $2.26 Million - $2.6 Million	9,739 New	9,739 $2.37 Million
Q3 2022 Nov 10, 2022	SELL	$51.03 - $264.23 $80,627 - $417,483	-1,580 Reduced 17.97%	7,213 $1.61 Million
Q2 2022 Aug 04, 2022	BUY	$234.74 - $275.42 $2.06 Million - $2.42 Million	8,793 New	8,793 $2.17 Million
Q2 2021 Aug 13, 2021	SELL	$232.65 - $254.58 $1.51 Million - $1.65 Million	-6,500 Closed	0 $0
Q4 2020 Feb 09, 2021	BUY	$221.92 - $245.94 $710,144 - $787,008	3,200 Added 96.97%	6,500 $1.63 Million
Q3 2020 Nov 16, 2020	BUY	$215.77 - $276.76 $712,041 - $913,308	3,300 New	3,300 $768,000
Q1 2019 May 15, 2019	SELL	$206.05 - $248.17 $1.07 Million - $1.28 Million	-5,174 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$204.73 - $257.93 $1.06 Million - $1.33 Million	5,174 New	5,174 $1.17 Million

1,738

250M

690K

787K

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $63.9B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

Get notified when there are updates to the investment portfolio of Seven Eight Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Seven Eight Capital, LP with notifications on news.